Henry Schein, Inc. (HSIC) — Fair Value Analysis
Base-case fair value (P50): $90.18 · Current price: $89.52 · Verdict: Fairly Valued
The Verdict on HSIC
Henry Schein (HSIC), a key player in the Healthcare sector, appears to be Fairly Valued based on our Monte Carlo simulations. With a current market price of $89.52, our median fair value (P50) stands at $90.18, implying an +0.7% upside. This narrow margin suggests that the market price closely reflects HSIC's intrinsic value under a wide range of future economic and operational scenarios. Investors should note this tight convergence when evaluating potential entry points for HSIC, as the stock is not presenting a significant discount or premium according to our probabilistic modeling.
How HSIC stacks up against Healthcare
HSIC's operational and financial health is categorized as average when compared to its peers within the Healthcare sector. This average quality tier indicates that while HSIC demonstrates solid fundamentals, it doesn't consistently outperform its industry counterparts on key metrics. The proximity of $89.52 to our $90.18 fair value further reinforces the view that the market has accurately priced this average performance relative to the broader sector landscape. While an +0.7% indicates some potential, it's not a compelling spread typically associated with deeply undervalued opportunities in the sector.
What this means for investors
Given that HSIC is currently trading near its Monte Carlo-derived median fair value of $90.18, with $89.52 reflecting an +0.7% potential, investors should approach the stock with a balanced perspective. The Fairly Valued verdict, combined with its average quality tier, suggests that significant outperformance from current levels may require specific positive catalysts or an improving fundamental outlook beyond what is currently factored into our simulations. For a comprehensive view, including the full bear-case (P10) and bull-case (P90) distribution, and to track HSIC's fair value as new fundamentals are released, sign up for a free FairCurve account.
Frequently Asked Questions
Is HSIC overvalued or undervalued right now?
Based on our Monte Carlo simulations, HSIC is currently Fairly Valued as its current price of $89.52 is very close to our median fair value estimate of $90.18.
What is the bear case and bull case for HSIC?
The full Monte Carlo distribution, including specific bear-case (P10) and bull-case (P90) targets, along with the probability of upside, is available with a free FairCurve account. We do not publish specific dollar values for these scenarios publicly.
How does FairCurve calculate HSIC's fair value?
FairCurve calculates HSIC's fair value using sophisticated Monte Carlo simulations, running thousands of forward scenarios to determine a probabilistic range of intrinsic values based on fundamental drivers.
How can I track HSIC's fair value as it changes?
You can add HSIC to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation alerts whenever new earnings reports or significant fundamental data are released.